The impact of continuous subcutaneous insulin infusion on health‐related quality of life in children and adolescents with type 1 diabetes

Aim: To study the impact of continuous subcutaneous insulin infusion (CSII) therapy on health‐related quality of life in children and adolescents with type 1 diabetes. Methods: 31 children and adolescents with poorly regulated type 1 diabetes (mean HbA1c 10.4%, SD 1.8), mean age 14.4 (1.5) y (range 9.7–17.1) and mean diabetes duration of 6.8 (3.2) y (range 1.3–14.6) were consecutively assigned to CSII therapy. Data for generic (CHQ‐CF87) and diabetes‐specific quality of life (DQOL) were obtained before initiating pump therapy and twice during 15 mo of treatment. HbA1c, BMI and episodes of severe hypoglycaemia and ketoacidosis were recorded over 15 mo prior to and 15 mo during pump therapy. Results: Analysis showed improvements on the family activity scale (p=0.041) and change in health score (p=0.042) (CHQ‐CF87). Mean HbA1c decreased from 10.4% (1.8) to 9.0% (0.9) after 3 mo, increasing to 9.6% (1.2) after 15 mo. The number of overweight and obese children increased from 4 and 2 before CSII, to 6 and 3 after 15 mo (IOTF criteria). There was a reduction in severe hypoglycaemia episodes from 43.8 to 5.2 per 100 patient years, but no change in ketoacidosis episodes.

[1]  P. Hougaard,et al.  Good metabolic control is associated with better quality of life in 2,101 adolescents with type 1 diabetes. , 2001, Diabetes care.

[2]  D. Marrero,et al.  A Modified Quality-of-Life Measure for Youths: Psychometric Properties , 1991, The Diabetes educator.

[3]  D. Cox,et al.  Maternal Fear of Hypoglycemia in their Children with Insulin Dependent Diabetes Mellitus , 1998, Journal of pediatric endocrinology & metabolism : JPEM.

[4]  T. Wysocki,et al.  Fear of hypoglycemia in children and adolescents with diabetes. , 1990, Journal of pediatric psychology.

[5]  E. Parton,et al.  Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes. , 2004, Pediatrics.

[6]  H. Chase,et al.  Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. , 2001, Pediatrics.

[7]  S. Nordfeldt,et al.  Fear and Other Disturbances of Severe Hypoglycaemia in Children and Adolescents with Type 1 Diabetes Mellitus , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[8]  Judith Green,et al.  Qualitative methods for health research , 2004 .

[9]  R. Rubin,et al.  How Diabetes Specialists Treat Their Own Diabetes: Findings From a Study of the AADE and ADA Membership , 2000, The Diabetes educator.

[10]  Darrell M. Wilson,et al.  A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. , 2005, Diabetes care.

[11]  O. Søvik,et al.  Evaluation of a programme of group visits and computer‐assisted consultations in the treatment of adolescents with Type 1 diabetes , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[12]  T. Jones,et al.  Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[13]  L. Egede,et al.  Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. , 2003, The Journal of pediatrics.

[14]  Reliability and Validity of a Diabetes Quality-of-Life Measure for the Diabetes Control and Complications Trial (DCCT) , 1988, Diabetes Care.

[15]  K. A. O’Donnell,et al.  Adolescent views of diabetes-related parent conflict and support: a focus group analysis. , 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[16]  N. Fineberg,et al.  Fear of Hypoglycemia in the Parents of Children and Adolescents With Diabetes: Maladaptive or Healthy Response? , 1997, The Diabetes educator.

[17]  W. Tamborlane,et al.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.

[18]  T. Erlinger,et al.  Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. , 2003, Diabetes care.

[19]  H. Arnqvist,et al.  Free insulin profiles during intensive treatment with biosynthetic human insulin. , 1988, Diabete & metabolisme.

[20]  V. Carey,et al.  Mixed-Effects Models in S and S-Plus , 2001 .

[21]  Knut-Andreas Christophersen,et al.  Health-related quality of life in a Norwegian sample of healthy adolescents: some psychometric properties of CHQ-CF87-N in relation to KINDL-N. , 2006, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[22]  P. Davidson,et al.  Reduction in Severe Hypoglycemia With Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes , 1996, Diabetes Care.

[23]  P. Cryer.  Hypoglycemia is the limiting factor in the management of diabetes , 1999, Diabetes/metabolism research and reviews.

[24]  K. Knafl,et al.  Parents' reflections on managing their children's diabetes with insulin pumps. , 2004, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[25]  T. Cole,et al.  Establishing a standard definition for child overweight and obesity worldwide: international survey , 2000, BMJ : British Medical Journal.

[26]  T. Skinner,et al.  Personal models of diabetes in relation to self-care, well-being, and glycemic control. A prospective study in adolescence. , 2001, Diabetes care.

[27]  Clare Bradley,et al.  Handbook of Psychology and Diabetes : A Guide to Psychological Measurement in Diabetes Research and Practice , 1994 .

[28]  Philip Hougaard,et al.  Comparison of Metabolic Control in a Cross-Sectional Study of 2,873 Children and Adolescents With IDDM from 18 Countries , 1997, Diabetes Care.